Bigul

Deccan Health Care Ltd - 542248 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company In Terms Of Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Closure Of Trading Window

Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2023 ,inter alia, to consider and approve 1. Raising of funds by way of Issue of Equity Shares /convertible warrants to Promoters / Promoters Group and person(s) other than promoters / Promoter Group on preferential basis, subject to obtaining approval of the shareholders of the Company. 2. Increase in authorized capital (if required) 3. Any other matter incidental and ancillary related to aforesaid above matters. 4. To consider and discuss any other Business with the permission of the Chairman. Further, the Trading Window will be closed with immediate effect and will continue to remain close till 48 hours after the submission of outcome of the Board Meeting to be held on Monday, August 28, 2023. Accordingly, all the designated persons /insiders of the Company are hereby informed that not to trade in the equity shares of the Company during the aforesaid period of closure of trading window
22-08-2023
Bigul

Deccan Health Care Ltd - 542248 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed herewith Newspaper Clippings of Unaudited Financial Results for the quarter ended on 30th June 2023 published in Financial Express (English Newspaper) and Mana Telenagana (Telangana Newspaper) Newspapers in pursuant to the Regulation 47 of SEBI (LODR) Regulations, 2015.
17-08-2023
Bigul

Deccan Health Care Ltd - 542248 - Results- Unaudited Financial Results June 30, 2023

Results-Unaudited Financial Results June 30, 2023
14-08-2023
Bigul

Deccan Health Care Ltd - 542248 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. August 14, 2023 And Submission Of Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2023

we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Monday, August 14, 2023 through Video Conferencing/OAVM have Inter-alia; 1. Considered and Approved the Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2023 along with the Limited Review Report. 2. Considered and Approved the Consolidated Unaudited Financial Results of the Company for the quarter ended on June 30, 2023 along with the Limited Review Report. 3. The Board has discussed about the favorable opportunity for the company opting for the issuance of equity shares/warrants on a preferential basis and authorized Dr. Minto Purshotam Gupta, Managing Director of the Company to identify the Prospective Investors, convene a board meeting to kickstart the proceedings for this initiative, as well as to establish crucial dates and address other pertinent matters.
14-08-2023
Bigul

Deccan Health Care Ltd - 542248 - Board Meeting Intimation for Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements), 2015

Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve 1. Unaudited Financial Results (Standalone & Consolidated) along with the Limited Review Report thereon of the Company for the First Quarter ended June 30, 2023. 2. To deliberate, discuss, and potentially endorse the enhancement of financial resources to support the expansion of offerings/New Products and the geographic reach of the online stores, namely www.beyoungstore.com and www.nutridecc.in. This entails securing funds through the preferential route, utilizing various avenues such as equity shares and/or warrants, in accordance with the provisions specified under Section 42 & 62 of the Companies Act, 2013, and in alignment with the relevant regulations delineated in Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The proposal shall extend to both existing and potential investors, including promoters, contingent upon obtaining the requisite approvals. 3. Any other business with the permission of the Chair.
07-08-2023
Bigul

Deccan Health Care Ltd - 542248 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In reference with the above subject, we wish to inform you that the entire holding of the Company is in Demat form and we have not received any dematerialization and rematerialization requests from any of the shareholders during the June 2023 quarter, hence the aforementioned regulation does not apply to the our Company. Certificate of Non-applicability as received from our RTA is attached with letter.
10-07-2023
Bigul

Deccan Health Care Ltd - 542248 - Closure of Trading Window

The Trading window of company shall remain closed from July 01, 2023 till 48 hours after announcement of Unaudited Financial Results for the quarter ended June 30, 2023.
30-06-2023
Bigul

Deccan Health Care Ltd - 542248 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

The Board of Directors has approved the appointment of M/s Keyur Shah and Associates as the Statutory Auditors of the company to fill the casual vacancy caused by resignation.
29-06-2023
Bigul

Deccan Health Care Ltd - 542248 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today, June 29, 2023

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Thursday, June 29, 2023 through Video Conferencing to considered and approved the following; 1. Pursuant to the recommendation of the Audit Committee, the Board of DHCL has considered and Approved the Appointment of M/s Keyur Shah & Associates, Chartered Accountants, as the Statutory Auditors of the Company W.e.f. June 29, 2023 to till Ensuing Annual General Meeting of the Company, subject to the approval of the Shareholders of the Company in General Meeting.Board has also recommended the firm for a period of 5 years from the conclusion of ensuing Annual General Meeting. 2. Approved the appointment of M/s M R Bhatia & Co., Company Secretary in Practice as Secretarial Auditor of the Company for the F.Y 2023-24.
29-06-2023
Bigul

Deccan Health Care Ltd - 542248 - Board Meeting Intimation for The Company In Terms Of Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2023 ,inter alia, to consider and approve the following matters: 1. Appointment of Statutory Auditor of the Company to fill Casual Vacancy till the next General Meeting 2. Appointment of Secretarial Auditor of the company for the F.Y 2023-24. 3. To consider and discuss any other Business with the permission of the Chairman. Kindly take the above information on your records.
26-06-2023
Next Page
Close

Let's Open Free Demat Account